State Street Corp Neurocrine Biosciences Inc Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 4,862,116 shares of NBIX stock, worth $652 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,862,116
Previous 4,891,137
0.59%
Holding current value
$652 Million
Previous $668 Million
19.46%
% of portfolio
0.02%
Previous 0.03%
Shares
21 transactions
Others Institutions Holding NBIX
# of Institutions
651Shares Held
96.9MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.9 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$742 Million0.37% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$358 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.5MShares$336 Million0.44% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...